The decreased COX-2 and GFAP expression in brain tissue of mice pre-treated with OM indicate the beneficial effect of this extract in attenuating the activation of pro-inflammatory pathways and the reactive astrogliosis, thus mitigating the inflammation-related neuronal death that is ultimately reflected in the protection against LPS-induced cognitive deterioration. The gene discussed is PTGS2; the disease is ocular melanoma.